Tolga Aslan
Ph.D.: Since 2014
Boğaziçi University, Molecular Biology and Genetics, Istanbul, Turkey
M.Sc.: 2006 – 2009
Boğaziçi University, Molecular Biology and Genetics, Istanbul, Turkey
B.Sc.: 2002 - 2006
Boğaziçi University, Molecular Biology and Genetics, Istanbul, Turkey
PKU, Gene therapy
Primary tissue culture, induced pluripotent stem cells, 2D gel electrophoresis, mass spectrometry, CRISPR-Cas9
Genetic analysis of rare inherited metabolic diseases in Turkish patients and development of personalized gene-therapy systems using primary tissue culture, animal models and Cas9 system.
Kavak E, Najafov A, Ozturk N, Seker T, Cavusoglu K, Aslan T, Duru AD, Saygili T, Hoxhaj G, Hiz MC, Unal DO, Birgül-Iyison N, Ozturk M, Koman A. (2010). Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets. Cellular Signaling. 22 (10), 1523-35.
Najafov A, Aslan T, Koman A. (2009). Wnt/β–Catenin Pathway Regulates Transcription of Actin – Regulatory Protein Mena. 4. Eortc Pathobiology Group Annual Meeting & 1. International Multidisciplinary Cancer Research Congress – Antalya
Kavak E, Najafov A, Ozturk N, Seker T, Cavusoglu K, Aslan T, Duru AD, Saygili T, Hoxhaj G, Hiz MC, Unal DO, Birgül-Iyison N, Ozturk M, Koman A. (2005). Identification of novel genes that are differentially expressed in ß-catenin/TCF4 signaling-activated hepatocellular carcinoma cells. Proceedings of the AACR-NCI- EORTC International Conference on Molecular Targets and Cancer Therapeutics, Pennsylvania USA
BIO342 Physiology laboratory
